+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gastrointestinal Bleeding Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026

  • ID: 4851220
  • Report
  • May 2019
  • Region: Global
  • 217 pages
  • Transparency Market Research
1 of 2

Global Gastrointestinal Bleeding Treatment Market: Overview

The global gastrointestinal bleeding treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, GI tract division, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global gastrointestinal bleeding treatment market.

Global Gastrointestinal Bleeding Treatment Market: Key Segments

In terms of product, the global gastrointestinal bleeding treatment market has been segmented into endoscopic hemostatic devices, closure devices, and others. The endoscopic hemostatic devices segment has been bifurcated into thermal devices and mechanical devices. Additionally, the market has been segmented based on the GI tract division and end-user.

Based on end-user, the global gastrointestinal bleeding treatment market has been classified into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment is anticipated to expand at a significant CAGR during the forecast period. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Gastrointestinal Bleeding Treatment Market: Regional Outlook

In terms of region, the global gastrointestinal bleeding treatment market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global gastrointestinal bleeding treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS plc, and US Medical Innovations, LLC.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Acronyms Used

3. Research Methodology

4. Executive Summary

5. Market Overview
5.1. Product Overview
5.2. Market Dynamics
5.2.1. Drivers
5.2.1.1. Increase in geriatric population
5.2.1.2. Government and non-government funding
5.2.1.3. High prevalence of upper gastrointestinal bleeding
5.2.1.4. Rise in applications of endoscopic hemostasis
5.2.1.5. Significant product launches
5.2.1.6. Strategic acquisitions
5.2.2. Restraints
5.2.2.1. Dearth of skilled labor
5.2.2.2. Product recalls
5.2.2.3. Limitations of endoscopic management
5.2.3. Opportunities
5.2.3.1. Increase in adoption of combination therapy
5.2.3.2. Untapped emerging economies
5.3. Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, 2016-2026
5.4. Global Gastrointestinal Bleeding Treatment Market Outlook
5.5. Key Industry Developments
5.6. Technological Advancements
5.7. Disease Epidemiological Assessment
5.8. Global Incidence of Gastrointestinal Cancers by Region
5.9. Reimbursement Scenario Assessment
5.10. Strategies Adopted by Top 3 Players
5.11. Healthcare Overview

6. Global Gastrointestinal Bleeding Treatment Market Analysis, by Product
6.1. Introduction
6.2. Key Findings
6.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product
6.4. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016-2026
6.4.1. Endoscopic Hemostatic Devices
6.4.1.1. Thermal Devices
6.4.1.2. Mechanical Devices
6.4.2. Closure Devices
6.4.3. Others
6.5. Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2018-2026

7. Global Gastrointestinal Bleeding Treatment Market Analysis, by GI Tract Division
7.1. Introduction
7.2. Key Findings
7.3. Market Value Share Analysis, by GI Tract Division
7.4. Market Value Forecast, by Procedure, 2016-2026
7.4.1. Upper GI Tract Division
7.4.2. Lower GI Tract Division
7.5. Market Attractiveness, by GI Tract Division

8. Global Gastrointestinal Bleeding Treatment Market Analysis, by End-user
8.1. Introduction
8.2. Key Findings
8.3. Market Value Share Analysis, by End-user
8.4. Market Value Forecast, by End-user, 2016-2026
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Ambulatory Surgical Centers
8.4.4. Others
8.5. Market Attractiveness, by End-user

9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecasts, by Region
9.1. Introduction
9.2. Regional Outlook
9.3. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Region, 2016-2026
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region

10. North America Gastrointestinal Bleeding Treatment Market Analysis
10.1. Key Findings
10.2. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Country, 2016-2026
10.2.1. U.S.
10.2.2. Canada
10.3. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016-2026
10.3.1. Endoscopic Hemostatic Devices
10.3.1.1. Thermal Devices
10.3.1.2. Mechanical Devices
10.3.2. Closure Devices
10.3.3. Others
10.4. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016-2026
10.4.1. Upper GI Tract
10.4.2. Lower GI Tract
10.5. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016-2026
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Ambulatory Surgical Centers
10.5.4. Others
10.6. North America Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product
10.6.3. By GI Tract Division
10.6.4. By End-user

11. Europe Gastrointestinal Bleeding Treatment Market Analysis
11.1. Key Findings
11.2. Europe Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016-2026
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016-2026
11.3.1. Endoscopic Hemostatic Devices
11.3.1.1. Thermal Devices
11.3.1.2. Mechanical Devices
11.3.2. Closure Devices
11.3.3. Others
11.4. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016-2026
11.4.1. Upper GI Tract
11.4.2. Lower GI Tract
11.5. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016-2026
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Ambulatory Surgical Centers
11.5.4. Others
11.6. Europe Market Attractiveness Analysis
11.6.1. By Country/Sub-region
11.6.2. By Product
11.6.3. By GI Tract Division
11.6.4. By End-user

12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis
12.1. Key Findings
12.2. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016-2026
12.2.1. China
12.2.2. India
12.2.3. Japan
12.2.4. Australia
12.2.5. Rest of Asia Pacific
12.3. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016-2026
12.3.1. Endoscopic Hemostatic Devices
12.3.1.1. Thermal Devices
12.3.1.2. Mechanical Devices
12.3.2. Closure Devices
12.3.3. Others
12.4. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016-2026
12.4.1. Upper GI Tract
12.4.2. Lower GI Tract
12.5. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016-2026
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Ambulatory Surgical Centers
12.5.4. Others
12.6. Asia Pacific Market Attractiveness Analysis
12.6.1. By Country/Sub-region
12.6.2. By Product
12.6.3. By GI Tract Division
12.6.4. By End-user

13. Latin America Gastrointestinal Bleeding Treatment Market Analysis
13.1. Key Findings
13.2. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016-2026
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016-2026
13.3.1. Endoscopic Hemostatic Devices
13.3.1.1. Thermal Devices
13.3.1.2. Mechanical Devices
13.3.2. Closure Devices
13.3.3. Others
13.4. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016-2026
13.4.1. Upper GI Tract
13.4.2. Lower GI Tract
13.5. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016-2026
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Ambulatory Surgical Centers
13.5.4. Others
13.6. Latin America Market Attractiveness Analysis
13.6.1. By Country/Sub-region
13.6.2. By Product
13.6.3. By GI Tract Division
13.6.4. By End-user

14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016-2026
14.2.1. GCC Countries
14.2.2. Israel
14.2.3. South Africa
14.2.4. Rest of Middle East & Africa
14.3. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016-2026
14.3.1. Endoscopic Hemostatic Devices
14.3.1.1. Thermal Devices
14.3.1.2. Mechanical Devices
14.3.2. Closure Devices
14.3.3. Others
14.4. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2016-2026
14.4.1. Upper GI Tract
14.4.2. Lower GI Tract
14.5. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2016-2026
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Ambulatory Surgical Centers
14.5.4. Others
14.6. Middle East & Africa Market Attractiveness Analysis
14.6.1. By Country/Sub-region
14.6.2. By Product
14.6.3. By GI Tract Division
14.6.4. By End-user

15. Competitive Landscape
15.1. Competition Matrix
15.2. Gastrointestinal Bleeding Treatment Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Boston Scientific Corporation
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Olympus Corporation
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. CONMED Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Cook Medical
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Ovesco Endoscopy AG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Erbe Elektromedizin GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Steris, plc
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. US Medical Innovations, LLC
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll